Physician profile
Daniel Evan Rosenberg
NPI 1790786192
$68,668.55
in general payments reported to CMS, 2019-2025
15 companies · $30K in 2025
The $30K reported for 2025 was more than what 94% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $8,988 · 2021: $92.65 · 2022: $120 · 2023: $2,731 · 2024: $8,436 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,013 · Consulting Fee: $7,956 · Food and Beverage: $3,205 · Travel and Lodging: $2,188 · Honoraria: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $18,762.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,012.50 |
| Consulting Fee | $7,956.25 |
| Food and Beverage | $3,205.42 |
| Travel and Lodging | $2,188.04 |
| Honoraria | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $37,737.57 | 2019-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $26,834.73 | 2019-2025 | Ozempic |
| Intuity Medical INC | $2,403.87 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Medtronic, INC. | $360.55 | 2021-2025 | Minimed 780g |
| Chiesi USA, INC. | $300.00 | 2025 | Mycapssa |
| Sanofi-Aventis U.S. LLC | $283.96 | 2019-2024 | |
| Amgen INC. | $253.71 | 2024-2025 | Evenity, Prolia |
| Beta Bionics, INC. | $165.80 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Dexcom, INC. | $114.62 | 2019-2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $99.08 | 2019-2020 | |
| Medtronic Minimed, INC. | $49.20 | 2019 | |
| Tandem Diabetes Care, INC. | $20.27 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Shire North American Group INC | $15.42 | 2019 | |
| Abbvie INC. | $15.00 | 2023 | Synthroid |
| Radius Health, INC. | $14.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.